SotalolBradycardia, hypotension and QTc prolongation

被引:0
|
作者
机构
关键词
D O I
10.1007/s40278-024-59795-2
中图分类号
学科分类号
摘要
引用
收藏
页码:539 / 539
相关论文
共 50 条
  • [31] Predictors of QTc and QTc prolongation in the generation scotland family study
    Brown, C. E.
    Hastie, C. E.
    Alghamdi, J.
    Schulz, C.
    Hocking, L. J.
    Luciano, M.
    Porteous, D.
    Morris, A.
    Smith, B. H.
    Dominiczak, A. F.
    Tobias, E. S.
    Delles, C.
    Padmanabhan, S.
    JOURNAL OF HUMAN HYPERTENSION, 2013, 27 (10) : 639 - 639
  • [32] QTc prolongation in apheresis platelet donors
    Laspina, SJ
    Browne, MA
    McSweeney, EN
    Lawlor, J
    Whelan, DM
    Kinsella, AI
    Murphy, WG
    TRANSFUSION, 2002, 42 (07) : 899 - 903
  • [33] An overview of QTc Prolongation with antipsychotics and antidepressants
    Bhandari, Samrat Singh
    Das, Shyamanta
    INDIAN JOURNAL OF PSYCHIATRY, 2022, 64 (SUPPL 3) : S643 - S643
  • [34] Drug-Induced QTc Prolongation
    Riad, Fady S.
    Davis, Andrew M.
    Moranville, Michael P.
    Beshai, John F.
    AMERICAN JOURNAL OF CARDIOLOGY, 2017, 119 (02): : 280 - 283
  • [35] Risk factors for QTc interval prolongation
    Heemskerk, Charlotte P. M.
    Pereboom, Marieke
    van Stralen, Karlijn
    Berger, Florine A.
    van den Bemt, Patricia M. L. A.
    Kuijper, Aaf F. M.
    van der Hoeven, Ruud T. M.
    Mantel-Teeuwisse, Aukje K.
    Becker, Matthijs L.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2018, 74 (02) : 183 - 191
  • [37] REGADENOSON AND QTC PROLONGATION: A PROSPECTIVE STUDY
    Damani, I.
    Damani, N.
    Menown, I.
    HEART, 2022, 108 : A7 - A8
  • [38] Galantamine-induced QTc prolongation
    Nelson, MW
    Buchanan, RW
    JOURNAL OF CLINICAL PSYCHIATRY, 2006, 67 (01) : 166 - 167
  • [39] QTc Prolongation During Treatment with Agomelatine
    Kozian, Ralf
    Syrbe, Guenther
    PSYCHIATRISCHE PRAXIS, 2010, 37 (08) : 405 - 407
  • [40] QTc prolongation and antipsychotics: a connection to remember
    Sousa, A.
    Gomes, J.
    Solana, C.
    Da Ponte, G.
    Paiva, A.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S518 - S519